Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics - results from a German observational study

Table 8 Laboratory test: patients with values out of the laboratory test reference range at baseline (Prev-AP, FAS, N = 642)

Blood-Test	Limit*		Prev-Olz	Prev-Risp	Prev-Quet	Prev-Atyp	Prev-Typ	Prev-Comb	Prev-None	FAS, total
			N = 62	N = 67	N = 49	N = 103	N = 90	N = 109	N = 162	N = 642
HbA_1c	≥6%	n	5	4	5	6	18	15	9	62
		%	8.1	6.0	10.2	5.8	20.0	13.8	5.6	9.7
Glucose	≥115 mg/dL	n	5	10	9	16	17	25	8	90
		%	8.1	14.9	18.4	15.7	18.9	23.2	4.9	14.1
Triglyceride	≥150 mg/dL	n	42	32	28	62	47	66	60	337
		%	67.7	47.8	57.1	60.2	52.2	60.6	37.0	52.5
HDL-Cholesterol	≤40 mg/dL	n	9	9	10	12	10	12	11	73
		%	14.5	13.4	20.4	11.7	11.1	11.0	6.8	11.4
C-reactive protein	≥3 mg/L	n	22	31	20	39	35	50	54	251
		%	35.5	46.3	40.8	37.9	38.9	45.9	33.3	39.1

Abbreviations: BMI = body mass index; FAS = full analysis set; HbA_1c = glycated hemoglobin; HDL = high density lipoprotein; Prev-AP = previous antipsychotic treatment cohort
* cutoffs as specified by laboratory

ISSN: 1471-244X